REFERENCES
- 2001 Report of the Auditor General of Canada Chapter 11—Illicit Drugs: The Federal Government's Role. Office of the Auditor General of Canada, Available: http://www.oag-bvg.gc.ca/domino/reports.nsf/html/01menu_e.html(Accessed January, 2002)
- Alford G. S., Koehler R. A., Leonard J. Alcoholics Anonymous-Narcotics Anonymous model inpatient treatment of chemically dependent adolescents: a 2-year outcome study. J. Stud. Alcohol. 1991; 52(2)118–126, [PUBMED], [INFOTRIEVE]
- American Society of Addiction Medicine. Public policy statement on national drug policy. J. Addict. Dis 1994; 13(4)231–234, [CSA], [CROSSREF]
- Bellm J. Needle-exchange programmes are not the answer [letter; comment]. Lancet 1999; 353(9165)1657–1661, [CROSSREF]
- Cartwright W. S. Cost-benefit and cost-effectiveness analysis of drug abuse treatment services. Evaluation Review 1988; 22(5)609–636, [CSA]
- Collins C., Coates T. J. Science and health policy: can they cohabit or should they divorce?. Am. J. Public Health 2000; 90(9)1389–1390, [PUBMED], [INFOTRIEVE], [CSA]
- Coutinho R. A. Needle exchange, pragmatism, and moralism. Am. J. Public Health 2000; 90(9)1387–1388, [PUBMED], [INFOTRIEVE], [CSA]
- Cox D. R. Regression models and life tables. J. Royal Stat. Soc. B 1972; 34: 187–202
- Craib K. J., Spittal P. M., Wood E., Laliberte N., Hogg R. S., Li K., et al. Risk factors for elevated HIV incidence among Aboriginal injection drug users in Vancouver. CMAJ 2003; 168(1)19–24, [PUBMED], [INFOTRIEVE], [CSA]
- Crits-Christoph P., Siqueland L., Blaine J., Frank A., Luborsky L., Onken L. S., et al. Psychosocial treatments for cocaine dependence: National Institute on Drug Abuse Collaborative Cocaine Treatment Study. Arch. Gen. Psychiatry 1999; 56(6)493–502, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Des Jarlais D. C. Research, politics, and needle exchange. Am. J. Public Health 2000; 90(9)1392–1394, [PUBMED], [INFOTRIEVE], [CSA]
- Des Jarlais D. C., Marmor M., Paone D., Titus S., Shi Q., Perlis T., et al. HIV incidence among injecting drug users in New York City syringe-exchange programmes. Lancet 1996; 348(9033)987–991, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Des Jarlais D. C., Paone D., Milliken J., Turner C. F., Miller H., Gribble J., et al. Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users: a quasi-randomised trial. Lancet 1999; 353(9165)1657–1661, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Drake S. Self-report among injecting drug users: a review. Drug Alcohol Depend. 1998; 51: 253–263, [CSA], [CROSSREF]
- Hartel D. M., Schoenbaum E. E. Methadone treatment protects against HIV infection: two decades of experience in the Bronx, New York City. Public Health Reports 1998; 113(Suppl 1)107–115, [PUBMED], [INFOTRIEVE]
- Johnson R. E., Chutuape M. A., Strain E. C., Walsh S. L., Stitzer M. L., Bigelow G. E. A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence. N. Engl. J. Med. 2000; 343(18)1290–1297, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Magura S. Introduction: program quality in substance dependency treatment. Subst. Use Misuse 2000; 35(12–14)1617–1627, [PUBMED], [INFOTRIEVE], [CSA]
- Miller C. L., Johnston C., Spittal P. M., Li K., Laliberte N., Montaner J. S., et al. Opportunities for prevention: hepatitis C prevalence and incidence in a cohort of young injection drug users. Hepatology 2002; 36(3)737–742, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Miller C. L., Tyndall M., Spittal P., Li K., Palepu A., Schechter M. T. Risk-taking behaviors among injecting drug users who obtain syringes from pharmacies, fixed sites, and mobile van needle exchanges. J. Urban Health 2002; 79(2)257–265, [PUBMED], [INFOTRIEVE], [CSA]
- Moss A. R. Epidemiology and the politics of needle exchange. Am. J. Public Health 2000; 90(9)1385–1387, [PUBMED], [INFOTRIEVE], [CSA]
- O'Shaughnessy M. V., Montaner J. S., Strathdee S., Schechter M. T. Deadly public policy. Int. Conf. AIDS 1998; 12: 982, (abstract no. 44233)[CSA]
- Palepu A., Strathdee S. A., Hogg R. S., Anis A. H., Rae S., Cornelisse P. G., et al. The social determinants of emergency department and hospital use by injection drug users in Canada. Journal of Urban Health 1999; 76(4)409–418, [PUBMED], [INFOTRIEVE], [CSA]
- Palepu A., Tyndall M. W., Leon H., Muller J., O'Shaughnessy M. V., Schechter M. T., et al. Hospital utilization and costs in a cohort of injection drug users. CMAJ 2001; 165(4)415–420, [PUBMED], [INFOTRIEVE], [CSA]
- Rehm J., Gschwend P., Steffen T., Gutzwiller F., Dobler-Mikola A., Uchtenhagen A. Feasibility, safety, and efficacy of injectable heroin prescription for refractory opioid addicts: a follow-up study. Lancet 2001; 358(9291)1417–1423, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Rydell C. P., Caulkins J. P., Everingham S. E. Enforcement or treatment? Modeling the relative efficacy of alternatives for controlling cocaine. Operations Research 1996; 44(5)687–695, [CSA]
- Schechter M. T. Science, ideology, and needle exchange programs. Annals of the American Academy of Political and Social Science 2002; 582: 94–101, [CSA], [CROSSREF]
- Schechter M. T., Strathdee S. A., Cornelisse P. G., Currie S., Patrick D. M., Rekart M. L., et al. Do needle exchange programmes increase the spread of HIV among injection drug users?: An investigation of the Vancouver outbreak. AIDS 1999; 13(6)F45–F51, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Sees K. L., Delucchi K. L., Masson C., Rosen A., Clark H. W., Robillard H., et al. Methadone maintenance vs. 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial [see comments]. JAMA 2000; 283(10)1303–1310, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Strathdee S. A., Galai N., Safaeian M., Celentano D. D., Vlahov D., Lisette J., et al. Sex differences in risk factors for HIV seroconversion among injection drug users: a ten year perspective. Archives of Internal Medicine 2001; 161: 1281–1288, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Strathdee S. A., Patrick D. M., Currie S. L., Cornelisse P. G., Rekart M. L., Montaner J. S., et al. Needle exchange is not enough: lessons from the Vancouver injecting drug use study. AIDS 1997; 11(8)F59–F65, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Tyndall M. W., Currie S., Spittal P., Li K., Wood E., O'Shaughnessy M. V., et al. Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic. AIDS 2003; 17(6)887–893, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Vlahov D. The role of epidemiology in needle exchange programs. Am. J. Public Health 2000; 90(9)1390–1392, [PUBMED], [INFOTRIEVE], [CSA]
- Wall R., Rehm J., Fischer B., Brands B., Gliksman L., Stewart J., et al Social costs of untreated opioid dependence. J. Urban Health 2000; 77(4)688–722, [PUBMED], [INFOTRIEVE], [CSA]
- Wenger L. D., Rosenbaum M. Drug treatment on demand—not. Journal of Psychoactive Drugs 1994; 26(1)1–11, [PUBMED], [INFOTRIEVE]
- Wood E., Kerr T., Montaner J. S., Strathdee S. A., Wodak A., Hankins C. A., et al. Rationale for evaluating North America's first medically supervised safer injecting facility. Lancet Infect. Dis. 2004; 4: 301–306, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Wood E., Kerr T., Spittal P. M., Li K., Small W., Tyndall M. W., et al. The potential public health and community impacts of safer injecting facilities: evidence from a cohort of injection drug users. J. Acquir. Immune Defic. Syndr. 2003; 32(1)2–8, [PUBMED], [INFOTRIEVE]
- Wood E., Kerr T., Spittal P. M., Tyndall M. W., O'Shaughnessy M. V., Schechter M. T. The healthcare and fiscal costs of the illicit drug use epidemic: the impact of conventional drug control strategies and the impact of a comprehensive approach. BCMJ 2003; 45(3)130–136
- Wood E., Montaner J. S., Schechter M. T., Tyndall M. W., O'Shaughnessy M. V., Hogg R. S. Prevalence and correlates of untreated HIV-1 infection in the era of modern antiretroviral therapy. Journal of Infectious Diseases 2003; 188(8)1164–1170, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Wood E., Spittal P. M., Kerr T., Small W., Tyndall M. W., O'Shaughnessy M. V., et al. Requiring help injecting as a risk factor for HIV infection in the Vancouver epidemic: implications for HIV prevention. Can. J. Public Health 2003; 94(5)355–359, [PUBMED], [INFOTRIEVE], [CSA]
- Wood E., Tyndall M. W., Spittal P. M., Li K., Anis A. H., Hogg R. S., et al. Supply-side policies for control of illicit drugs in the face of the AIDS and overdose epidemics: investigation of a massive heroin seizure. CMAJ 2003; 168(2)165–169, [PUBMED], [INFOTRIEVE], [CSA]
- Wood E., Tyndall M. W., Spittal P. M., Li K., Hogg R. S., Montaner J. S., et al. Factors associated with persistent high-risk syringe sharing in the presence of an established needle exchange programme. AIDS 2002; 16(6)941–943, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Wood E., Tyndall M. W., Spittal P., Li K. R. S. H., O'Shaughnessy M., et al. Needle exchange and difficulty with needle access during an ongoing HIV epidemic. International J. Drug Policy 2002; 13(2)95–102, [CSA], [CROSSREF]